ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
Clinical trial NCT04843761 · COMPLETED
Trial details
- NCT number
- NCT04843761
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2022-08-22
- Enrollment
- 473
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.